Brian Halak, Angel Investor

Brian Halak is a Partner at Domain Associates, a role he has held for more than two decades, and a Practice Professor at the University of Pennsylvania. Previously, he was the Founder and CEO of Nobias Therapeutics and the Founder and CEO of WindMIL Therapeutics. Brian is also an angel investor. His investment and company creation activities have included Tobira Therapeutics, which developed treatments for liver and infectious diseases, Elite NeuroVascular, focused on devices for stroke treatment, WindMIL Therapeutics, developing cellular immunotherapies, and Nobias Therapeutics, which advanced AI-driven drug discovery. He brings deep experience in biotech investing, company formation, and fundraising, combining his scientific and business background to support transformative healthcare innovations from inception through successful financing and exit.